PAQR4 has a tumorigenic effect in human breast cancers in association with reduced CDK4 degradation

Huanhuan Zhang1,2, Ruomei Han1,2, Zhi-Qiang Ling3

  • 1Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, China.

Carcinogenesis
|December 12, 2017
PubMed

Insights

Progestin and adipoQ receptor 4 (PAQR4) promotes breast cancer growth by increasing cell proliferation and tumor formation. It also affects cyclin-dependent kinases 4 (CDK4) protein levels, impacting patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Progestin and adipoQ receptor 4 (PAQR4) is part of a family involved in metabolism and cancer.
  • The role of PAQR4 in human cancers, particularly breast cancer, is not well understood.

Purpose of the Study:

  • To investigate the function of PAQR4 in human breast cancer development and progression.
  • To explore the molecular mechanisms underlying PAQR4's role in breast cancer.

Main Methods:

  • Analysis of PAQR4 expression in human breast cancer tissues using the ONCOMINE database and patient samples.
  • In vitro studies involving PAQR4 knockdown and overexpression in breast cancer cell lines (SUM159, MCF7) to assess proliferation and colony formation.
  • In vivo tumor xenograft models to evaluate the effect of PAQR4 on tumor growth.
  • Investigation of PAQR4's impact on cyclin-dependent kinases 4 (CDK4) protein levels, degradation, and polyubiquitination.

Main Results:

  • PAQR4 is significantly upregulated in human breast cancer tissues compared to normal tissues.
  • Higher PAQR4 mRNA levels correlate with poorer disease-free and overall survival in breast cancer patients.
  • PAQR4 overexpression enhances breast cancer cell proliferation, colony formation, and tumor growth in vivo.
  • PAQR4 knockdown suppresses these processes.
  • PAQR4 negatively regulates CDK4 protein levels by modulating its degradation and polyubiquitination.

Conclusions:

  • PAQR4 exhibits a tumorigenic effect in human breast cancer.
  • PAQR4's oncogenic role is linked to its modulation of CDK4 protein stability.
  • PAQR4 represents a potential therapeutic target for breast cancer treatment.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K